Drug administration with TASK-1 and TASK-3 channel inhibitors and its application in the treatment of respiratory disorders

摘要

This application relates to the management of new drugs containing highly selective inhibitors of TASK-1 and / or TASK-3 channels, as well as the treatment and / or prevention of respiratory disorders, including sleep related respiratory disorders (such as obstructive apnea) and Central apnea in sleep and snoring, / P